Schizophrenia with hypozincemia: Clinical features and symptom severity
Koichi Tabata(Tokyo Medical and Dental University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Masanari Itokawa(Fujita Health University), Syudo Yamasaki(The University of Tokyo), Kazuhiro Suzuki(National Institute of Health Sciences), Hidehiko Takahashi(Institute of Science Tokyo), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Ryota Hashimoto(National Center of Neurology and Psychiatry), Kazuhiro Niizato(Tokyo Metropolitan Matsuzawa Hospital), Isabella Supardi Parida(Tohoku University), Yukihiro Nagase(Takatsuki General Hospital), Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Kenichi Oshima(Tokyo Metropolitan Matsuzawa Hospital), Atsushi Nishida(Tokyo Institute of Psychiatry), Atsushi Imai(Tokyo Metropolitan Matsuzawa Hospital)
Cited by 0
Related Papers
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
|Molecular Psychiatry|2017|733
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184